Xenoestrogen exposure and mechanisms of endocrine disruption.
about
Xenoestrogens at picomolar to nanomolar concentrations trigger membrane estrogen receptor-alpha-mediated Ca2+ fluxes and prolactin release in GH3/B6 pituitary tumor cellsThe G-protein-coupled estrogen receptor GPER in health and diseasePolychlorinated biphenyls and links to cardiovascular diseaseAssessment and molecular actions of endocrine-disrupting chemicals that interfere with estrogen receptor pathways.Nongenomic signaling pathways of estrogen toxicity.Increased level of cellular Bip critically determines estrogenic potency for a xenoestrogen kepone in the mouse uterus.Endocrine disrupters: a review of some sources, effects, and mechanisms of actions on behaviour and neuroendocrine systems.Xenoestrogens are potent activators of nongenomic estrogenic responses.International Union of Basic and Clinical Pharmacology. XCVII. G Protein-Coupled Estrogen Receptor and Its Pharmacologic ModulatorsNongenomic actions of low concentration estrogens and xenoestrogens on multiple tissues.Gene expression profiling identifies lobe-specific and common disruptions of multiple gene networks in testosterone-supported, 17beta-estradiol- or diethylstilbestrol-induced prostate dysplasia in Noble rats.The ins and outs of GPR30: a transmembrane estrogen receptorSignaling, physiological functions and clinical relevance of the G protein-coupled estrogen receptor GPER.Protective Effects of Lycium barbarum Polysaccharides on Testis Spermatogenic Injury Induced by Bisphenol A in Mice.Prenatal stress and development: beyond the single cause and effect paradigm.GPER modulators: Opportunity Nox on the heels of a class Akt.The xenoestrogens ethinylestradiol and bisphenol A regulate BCRP at the blood-brain barrier of rats.Biodepollution of wastewater containing phenolic compounds from leather industry by plant peroxidases.Alteration of brain and interrenal StAR protein, P450scc, and Cyp11beta mRNA levels in atlantic salmon after nominal waterborne exposure to the synthetic pharmaceutical estrogen ethynylestradiol.Inhibitor of Differentiation-3 and Estrogenic Endocrine Disruptors: Implications for Susceptibility to Obesity and Metabolic Disorders.
P2860
Q24814754-16368E5C-35CC-4F6C-A3D5-61784A9A4128Q27013052-3E2F02C8-CE23-46C1-88D2-599032B25E77Q28391417-45303652-86D9-44DF-A343-33F5A5FFE762Q30393711-8E56D1C5-A087-4A0A-AB33-74905AB2E0F6Q33988964-763743DF-44A0-43E4-838B-AD2E93299936Q34665636-84ED1A50-B8F8-4247-B577-1CC68B3DCBF0Q35631805-DA1C686F-F788-4B2F-98C8-9F0ABAD854F5Q35776394-5449CCF2-9FCF-4D66-8EEF-75B17442BFE9Q35795751-3A5204F1-E212-4C7A-B0C8-732A119C64E7Q36003029-1456FFEC-6085-41E8-AD6B-C9FCC96CDD2EQ36409841-9E41136C-3F2C-4831-B58D-9AC5D833BE0EQ36787619-427888C2-B306-444B-BE07-BC8BC98705D1Q37339848-24CDA90D-227F-4F56-ABEB-0480B4729527Q37465793-08E9A835-E656-4C25-AB73-141DC89847F5Q38160820-3325F5C8-C451-42F4-BDEF-D6DA484A0571Q39174507-DDE8A458-2ED8-40A1-9036-84A341E07A2DQ42705146-DB6B0108-3F33-47A7-9DD2-6E1AC9649574Q43320568-91546B8C-2483-461C-A612-FD9FFDD0DAC4Q48238536-AD65E6CC-7E81-4E64-878E-40E7AA58505DQ51765567-6D564AFC-A0D9-4AE5-BB87-0CEA95888044
P2860
Xenoestrogen exposure and mechanisms of endocrine disruption.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Xenoestrogen exposure and mechanisms of endocrine disruption.
@ast
Xenoestrogen exposure and mechanisms of endocrine disruption.
@en
type
label
Xenoestrogen exposure and mechanisms of endocrine disruption.
@ast
Xenoestrogen exposure and mechanisms of endocrine disruption.
@en
prefLabel
Xenoestrogen exposure and mechanisms of endocrine disruption.
@ast
Xenoestrogen exposure and mechanisms of endocrine disruption.
@en
P356
P1476
Xenoestrogen exposure and mechanisms of endocrine disruption.
@en
P2093
David W Singleton
Sohaib A Khan
P304
P356
10.2741/1010
P577
2003-01-01T00:00:00Z